1-12 of 12
Anthony J. Murgo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessment of Audit Methodologies for Bias Evaluation of Tumor Progression in Oncology Clinical Trials

Jenny J. Zhang, Lijun Zhang, Huanyu Chen, Anthony J. Murgo, Lori E. Dodd, Richard Pazdur, Rajeshwari Sridhara
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (10): 2637–2645.
https://doi.org/10.1158/1078-0432.CCR-12-3364
Published: 12 May 2013
View article titled, Assessment of Audit Methodologies for Bias Evaluation of Tumor Progression in Oncology Clinical Trials
Open the PDF for Assessment of Audit Methodologies for Bias Evaluation of Tumor Progression in Oncology Clinical Trials in another window
Journal Articles

Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α in Advanced Solid Tumors

Shivaani Kummar, Mark Raffeld, Lamin Juwara, Yvonne Horneffer, Agnes Strassberger, Deborah Allen, Seth M. Steinberg, Annamaria Rapisarda, Shawn D. Spencer, William D. Figg, Xiaohong Chen, Ismail Baris Turkbey, Peter Choyke, Anthony J. Murgo, James H. Doroshow, Giovanni Melillo
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 5123–5131.
https://doi.org/10.1158/1078-0432.CCR-11-0682
Published: 31 July 2011
View article titled, Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α in Advanced Solid Tumors
Open the PDF for Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α in Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells

Lihua H. Wang, Thomas D. Pfister, Ralph E. Parchment, Shivaani Kummar, Larry Rubinstein, Yvonne A. Evrard, Martin E. Gutierrez, Anthony J. Murgo, Joseph E. Tomaszewski, James H. Doroshow, Robert J. Kinders
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (3): 1073–1084.
https://doi.org/10.1158/1078-0432.CCR-09-2799
Published: 01 February 2010
View article titled, Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells
Open the PDF for Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells in another window
Includes: Supplementary data
Journal Articles

Designing Phase 0 Cancer Clinical Trials

Anthony J. Murgo, Shivaani Kummar, Larry Rubinstein, Martin Gutierrez, Jerry Collins, Robert Kinders, Ralph E. Parchment, Jiuping Ji, Seth M. Steinberg, Sherry X. Yang, Melinda Hollingshead, Alice Chen, Lee Helman, Robert Wiltrout, Joseph E. Tomaszewski, James H. Doroshow
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (12): 3675–3682.
https://doi.org/10.1158/1078-0432.CCR-07-4560
Published: 16 June 2008
View article titled, Designing Phase 0 Cancer Clinical Trials
Open the PDF for Designing Phase 0 Cancer Clinical Trials in another window
Journal Articles

Improving the Quality of Abstract Reporting for Phase I Cancer Trials

Elizabeth L. Strevel, Nicole G. Chau, Gregory R. Pond, Anthony J. Murgo, Percy S. Ivy, Lillian L. Siu
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (6): 1782–1787.
https://doi.org/10.1158/1078-0432.CCR-07-4886
Published: 17 March 2008
View article titled, Improving the Quality of Abstract Reporting for Phase I Cancer Trials
Open the PDF for Improving the Quality of Abstract Reporting for Phase I Cancer Trials in another window
Journal Articles

Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, Administered Weekly in Refractory Solid Tumors and Lymphoid Malignancies

Shivaani Kummar, Martin Gutierrez, Erin R. Gardner, Erin Donovan, Kyunghwa Hwang, Eun Joo Chung, Min-Jung Lee, Kim Maynard, Mikhail Kalnitskiy, Alice Chen, Giovanni Melillo, Qin C. Ryan, Barbara Conley, William D. Figg, Jane B. Trepel, James Zwiebel, James H. Doroshow, Anthony J. Murgo
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5411–5417.
https://doi.org/10.1158/1078-0432.CCR-07-0791
Published: 17 September 2007
View article titled, Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, Administered Weekly in Refractory Solid Tumors and Lymphoid Malignancies
Open the PDF for Phase I Trial of MS-275, a Histone Deacetylase Inhibitor, Administered Weekly in Refractory Solid Tumors and Lymphoid Malignancies in another window
Journal Articles

Phase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) Lymphoma

John D. Roberts, Mitchell R. Smith, Eric J. Feldman, Louise Cragg, Michael M. Millenson, Gail J. Roboz, Connie Honeycutt, Rose Thune, Kristin Padavic-Shaller, W. Hans Carter, Viswanathan Ramakrishnan, Anthony J. Murgo, Steven Grant
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5809–5816.
https://doi.org/10.1158/1078-0432.CCR-05-2730
Published: 04 October 2006
View article titled, Phase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) Lymphoma
Open the PDF for Phase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) Lymphoma in another window
Journal Articles

Phase I Study of Decitabine-Mediated Gene Expression in Patients with Cancers Involving the Lungs, Esophagus, or Pleura

David S. Schrump, Maria R. Fischette, Dao M. Nguyen, Ming Zhao, Xinmin Li, Tricia F. Kunst, Ana Hancox, Julie A. Hong, G. Aaron Chen, Vitaliy Pishchik, William D. Figg, Anthony J. Murgo, Seth M. Steinberg
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5777–5785.
https://doi.org/10.1158/1078-0432.CCR-06-0669
Published: 04 October 2006
View article titled, Phase I Study of Decitabine-Mediated Gene Expression in Patients with Cancers Involving the Lungs, Esophagus, or Pleura
Open the PDF for Phase I Study of Decitabine-Mediated Gene Expression in Patients with Cancers Involving the Lungs, Esophagus, or Pleura in another window
Includes: Supplementary data
Journal Articles

Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

Patrick Y. Wen, W.K. Alfred Yung, Kathleen R. Lamborn, Patricia L. Dahia, Yanfeng Wang, Bin Peng, Lauren E. Abrey, Jeffrey Raizer, Timothy F. Cloughesy, Karen Fink, Mark Gilbert, Susan Chang, Larry Junck, David Schiff, Frank Lieberman, Howard A. Fine, Minesh Mehta, H. Ian Robins, Lisa M. DeAngelis, Morris D. Groves, Vinay K. Puduvalli, Victor Levin, Charles Conrad, Elizabeth A. Maher, Kenneth Aldape, Michael Hayes, Laurie Letvak, Merrill J. Egorin, Renaud Capdeville, Richard Kaplan, Anthony J. Murgo, Charles Stiles, Michael D. Prados
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (16): 4899–4907.
https://doi.org/10.1158/1078-0432.CCR-06-0773
Published: 16 August 2006
View article titled, Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08
Open the PDF for Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08 in another window
Journal Articles

Effects of α1-Acid Glycoprotein on the Clinical Pharmacokinetics of 7-Hydroxystaurosporine

Alex Sparreboom, Huachen Chen, Milin R. Acharya, Adrian M. Senderowicz, Richard A. Messmann, Takashi Kuwabara, David J. Venzon, Anthony J. Murgo, Donna Headlee, Edward A. Sausville, William D. Figg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (20): 6840–6846.
https://doi.org/10.1158/1078-0432.CCR-04-0805
Published: 22 October 2004
View article titled, Effects of α<sub>1</sub>-Acid Glycoprotein on the Clinical Pharmacokinetics of 7-Hydroxystaurosporine
Open the PDF for Effects of α<sub>1</sub>-Acid Glycoprotein on the Clinical Pharmacokinetics of 7-Hydroxystaurosporine in another window
Journal Articles

Phase I and Correlative Study of Combination Bryostatin 1 and Vincristine in Relapsed B-Cell Malignancies

Afshin Dowlati, Hillard M. Lazarus, Paul Hartman, James W. Jacobberger, Cecilia Whitacre, Stanton L. Gerson, Pamela Ksenich, Brenda W. Cooper, Phyllis S. Frisa, Megan Gottlieb, Anthony J. Murgo, Scot C. Remick
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5929–5935.
Published: 15 December 2003
View article titled, Phase I and Correlative Study of Combination Bryostatin 1 and Vincristine in Relapsed B-Cell Malignancies
Open the PDF for Phase I and Correlative Study of Combination Bryostatin 1 and Vincristine in Relapsed B-Cell Malignancies in another window
Journal Articles

Phase I Study of Low-Dose Suramin as a Chemosensitizer in Patients with Advanced Non-Small Cell Lung Cancer

Miguel A. Villalona-Calero, M. Guillaume Wientjes, Gregory A. Otterson, Steven Kanter, Donn Young, Anthony J. Murgo, Beth Fischer, Carrie DeHoff, Danny Chen, Teng-Kuang Yeh, SaeHeum Song, Michael Grever, Jessie L-S. Au
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3303–3311.
Published: 05 September 2003
View article titled, Phase I Study of Low-Dose Suramin as a Chemosensitizer in Patients with Advanced Non-Small Cell Lung Cancer
Open the PDF for Phase I Study of Low-Dose Suramin as a Chemosensitizer in Patients with Advanced Non-Small Cell Lung Cancer in another window